書誌事項
- タイトル別名
-
- A case of bisphosphonate-associated osteonecrosis of the maxilla in a patient with multiple myeloma
- タハツセイ コツズイシュ ニ タイスル ビスフォスフォネート トウヨ ニ カンレンシタ ト カンガエラレル ジョウガクコツ エシ ノ 1レイ
この論文をさがす
抄録
Bisphosphonates (BPs) inhibit bone resorption and are widely used to treat skeletal complications in patients with the bone metastasis from malignant tumors, osteoporosis, and bone lesions of multiple myeloma. Osteonecrosis of the jaw (ONJ) has been associated with the use of BP. In Japan, zoledronic acid has been used to treat bone lesions of multiple myeloma and bone metastasis from malignant tumors since April 2006. Zoledronic acid has strong bone antiresorptive activity as compared with other BPs such as pamidronate. The number of patients given zoledronic acid and the frequency of ONJ are expected to increase in Japan.<BR>We report a patient with ONJ who was given zoledronic acid to prevent bone lesions of multiple myeloma. A 78-year-old man was referred to our hospital to undergo evaluation of bilateral asymptomatic bone exposure of the maxillary molar regions. MR imaging showed a low-signal-density area in the left maxillary molar region. Histopathologically, a biopsy specimen showed sequestration with attachment of bacteria. A final diagnosis of ONJ was made. Conservative follow-up is being continued, and no symptoms have developed.
収録刊行物
-
- 日本口腔外科学会雑誌
-
日本口腔外科学会雑誌 54 (4), 256-260, 2008
社団法人 日本口腔外科学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001206531609216
-
- NII論文ID
- 10027088449
-
- NII書誌ID
- AN00189163
-
- ISSN
- 21861579
- 00215163
-
- NDL書誌ID
- 9497647
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可